Rationale Pharma Private Limited - Company Profile

It is a business services private limited company based in Pune City, Maharashtra, India, established in 2026.
2026 Pune City, Maharashtra, India Active
Last Updated:
About Rationale Pharma Private Limited

Rationale Pharma Private Limited, a active private limited company, was established on 07 January 2026 in Pune City, Maharashtra, India. it holds CIN: U46497PN2026PTC250406. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.60 M.

Formerly known as Rationale Pharma Private Limited. Its leadership includes Priyanka Sudarshan Patil (Director), Bhushan Manohar Deore (Director), Priti Pankaj Salunke (Director). It is based at P N 22 Pratham S N 210/34, Wakad, Tal Mulshi, Pune City, Maharashtra, 411027.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497PN2026PTC250406

  • Registration Number

    250406

  • Incorporation Date

    07 January 2026

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.60 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.60 M
  • Company Age 2 Months 20 Days
Company report

Rationale Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rationale Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Rationale Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Priyanka Sudarshan Patil Director 07 Jan 2026 Current
Bhushan Manohar Deore Director 07 Jan 2026 Current
Priti Pankaj Salunke Director 07 Jan 2026 Current
Sharda Dhananjay Ture Director 07 Jan 2026 Current
Archita Anant Patil Director 07 Jan 2026 Current
Sonali Rahul Ambegaonkar Director 07 Jan 2026 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rationale Pharma.
Rationale Pharma revenue growth over time
Rationale Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rationale Pharma?

Unlock access to Rationale Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Rationale Pharma?

Unlock and access historical data on people associated with Rationale Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rationale Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rationale Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rationale Pharma
Recent Activity within the Organization
  • Director Appointment

    Priyanka Sudarshan Patil was appointed as a Director was appointed as a Director on 07 Jan 2026 & has been associated with this company since 2 months 20 days . was recorded as a recent event.

  • Director Appointment

    The activity Bhushan Manohar Deore was appointed as a Director was appointed as a Director on 07 Jan 2026 & has been associated with this company since 2 months 20 days . was completed.

  • Director Appointment

    Progress on Priti Pankaj Salunke was appointed as a Director was appointed as a Director on 07 Jan 2026 & has been associated with this company since 2 months 20 days . was documented.

  • Director Appointment

    The activity Sharda Dhananjay Ture was appointed as a Director was appointed as a Director on 07 Jan 2026 & has been associated with this company since 2 months 20 days . was completed.

  • Director Appointment

    The activity Archita Anant Patil was appointed as a Director was appointed as a Director on 07 Jan 2026 & has been associated with this company since 2 months 20 days . was completed.

  • Company Incorporation

    The activity Rationale Pharma Private Limited was registered on 07 Jan 2026 with Roc Pune & aged 2 months 20 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rationale Pharma Private Limited?

The CIN of Rationale Pharma Private Limited is U46497PN2026PTC250406.

Where is Rationale Pharma Private Limited headquartered?

Rationale Pharma Private Limited is headquartered at P N 22 Pratham S N 210/34, Wakad, Tal Mulshi, Pune City, Maharashtra, 411027.

When was Rationale Pharma Private Limited incorporated?

Rationale Pharma Private Limited was incorporated on 07 January 2026.

Who are the current directors of Rationale Pharma Private Limited?
Is Rationale Pharma Private Limited a listed company?

Rationale Pharma Private Limited is unlisted.

What is the capital structure of Rationale Pharma Private Limited?

The authorized capital of Rationale Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.60 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available